Skip to content

Active aGeing And Personalised Service's Ecosystem (AGAPE) Aims to Implement an Advanced Technology Platform That Provides Services to the Elderly, Formal and Informal Caregivers, and Caregiving Organizations

Active aGeing And Personalised Service's Ecosystem

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06859489
Acronym
AGAPE
Enrollment
68
Registered
2025-03-05
Start date
2024-02-06
Completion date
2025-03-31
Last updated
2025-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digital Health Literacy, Older People

Keywords

active and healthy ageing, digital health literacy, older adults

Brief summary

AGAPE aims to implement an advanced technology platform that provides services to older adults, formal and informal caregivers, and caregiving organizations.

Detailed description

AGAPE aims to promote an active and healthy lifestyle in the over-65 population and, in parallel, to improve the quality of life of caregivers (by reducing the burden of care), while also overcoming the possible digital literacy gap of users. The advantage of the AGAPE platform is to offer users highly personalized services based on their needs and digital capabilities, and innovative technologies integrated with each other that fit within the spatial services already available in local ecosystems. The project involves an impact-by-design approach that engages older people, caregivers, and managers of care organizations in a co-creation strategy. In addition, the solutions offered by the AGAPE platform will be extensively tested in a preliminary pre-validation phase in order to effectively meet the needs of end users.

Interventions

DEVICEActive aGeing And Personalised service's Ecosystem (AGAPE)

The experimental protocol is structured into two phases: Phase 1 (pre-pilot) - Preliminary assessment of the functionality and usability of the AGAPE platform by older adults and caregivers, divided into: Living lab: Three sessions to progressively explore and test the platform and its services, including workshop activities. Testing phase: Use of the platform in the home environment of older adults for one month. Phase 2 (pilot study) - Evaluation of the platform's impact on the daily lives of older adults, caregivers, and care organizations, with a 12-month involvement for each user.

Sponsors

MEDEA SRL
CollaboratorUNKNOWN
Carol Davila University of Medicine and Pharmacy
CollaboratorOTHER
Caritas Diocesana de Coimbra
CollaboratorUNKNOWN
Be-Com
CollaboratorUNKNOWN
SenLab d.o.o.
CollaboratorUNKNOWN
Umana Persone
CollaboratorUNKNOWN
Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Four categories of end users will be involved: 1. Primary end users (i.e., older adults); 2. Secondary end users, in the figure of informal caregivers (i.e., relatives and friends of the elderly); 3. Secondary end users, in the figure of formal caregivers (i.e., social and health workers with different professional trainings, such as nurses, home care workers, geriatricians etc...); 4. Tertiary end users (i.e., care organizations, local authorities, municipalities). The Agape platform will offer a series of customized and integrated services to meet the needs of end users, including: 1. promotion of a healthy and active lifestyle; 2. socialization services; 3. digital health literacy service.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 65 years * Ability to understand the rationale and characteristics of the study and to provide informed consent * Low level of frailty, indicated by a score \<5 on the Rockwood Clinical Frailty Scale (Rockwood et al., 2005) * Absence of moderate to severe cognitive impairment, indicated by a Mini-Mental State Examination (MMSE) score ≥ 24 (adjusted score; Folstein, 1975) * Absence of severe comorbidities and clinically relevant diseases

Exclusion criteria

* Age below 65 years * Inability to provide informed consent for participation in the study * High level of frailty (Rockwood Clinical Frailty Scale \> 5) * Presence of cognitive impairment (adjusted MMSE score \< 24) * Diagnosed anxiety and depression * Presence of severe disability and serious health conditions

Design outcomes

Primary

MeasureTime frameDescription
System Usability Scale (SUS)From the enrollment to the end of treatment at 12 months (T2)Innovation adoption profile transition of the older adult, innovation adoption profile transition of the caregiver, evaluation of usability and technostress levels of the older adult and their respective caregivers in relation to the AGAPE platform, assessed using the SUS scale and the Technostress questionnaire throughout the different phases of the study. Answer: 1 (strongly disagree) - 5 (strongly agree). Minimum= 10 ; Maximum= 50.
Ad Hoc socio-demographic questionnaireFrom the enrollment to 6 months (T1)the aim of the questionnaire is recording the socio-demographic charateristics of the sample
TechnoStress QuestionnaireFrom the enrollment to 12 months (T2)it's a psychological questionnaire designed to measure the level of stress related to the use of technology.
Questionnaire for Innovation AdoptionFrom the enrollment to1 month (T0)it explores how and why individuals decide to embrace or reject innovation such as technology
EQ-5D-5LFrom the enrollment to1 month (T0)this questionnaire explores the quality of life for european samples. Answer: 1 (no problems) to 5 (extreme problems).
UCLA Loneliness ScaleFrom the enrollment to 6 months (T1)this scale is used for investigate the loneliness of the sample. Answer: 0 (Never) to 3 (Often).

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026